Impact of comorbidities on response outcomes in patients with chronic myeloid leukemia in chronic phase treated with first-line dasatinib versus imatinib: Exploratory post hoc analysis of DASISION Meeting Abstract
| Authors: | Breccia, M.; Mauro, M. J.; Jabbour, E.; Saglio, G.; Jimenez-Velasco, A.; le Coutre, P. D.; DeGutis, I.; Khan, W.; Sy, O.; Swanink, R.; Cortes, J. E. |
| Abstract Title: | Impact of comorbidities on response outcomes in patients with chronic myeloid leukemia in chronic phase treated with first-line dasatinib versus imatinib: Exploratory post hoc analysis of DASISION |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-01 |
| Language: | English |
| ACCESSION: | WOS:000607547200113 |
| DOI: | 10.1182/blood-2020-137636 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 31 -- Source: Wos |
